Jennifer Cochran

Jennifer Cochran is the founder of TwoStep Therapeutics, Inc., founded in 2024, with no titles listed.
Dr. Cochran is the founder of Red Tree Venture Capital, founded in 2020, with no titles listed.
Dr. Cochran is the founder of Switch Bioworks, Inc., founded in 2022, serving as Director.
Dr. Cochran was also the founder of xCella Biosciences, Inc...
Dr. Cochran was previously Director at Revel Pharmaceuticals, Inc., Director at Virsti Therapeutics, Inc., Independent Director at OmniAb Operations, Inc., Independent Director at OmniAb, Inc. since 2022, Director at Biograph 55, Inc., Director at Rondo Therapeutics, Inc., Director at Tachyon Therapeutics, Inc., Director at Kivu Bioscience, Inc., Director at Excellergy Therapeutics, and Professor at Stanford University since 2005.
Former positions include Independent Director at Ligand Pharmaceuticals, Inc., Director at Combangio, Inc., Director at Nodus Therapeutics, Inc., and Chief Scientist at Lagunita Biosciences LLC from 2015 to 2020.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Delaware.